Platelet BioGenesis

United States
Glenview, Illinois, United States, 02472

Company profile

Platelet BioGenesis company profile

Platelet BioGenesis specializes in the fields of biotechnology, platelets, and drug discovery. They discover a new category in therapeutics. The company is developing technology to produce donor-independent human platelets from human induced pluripotent stem cells.

Business identity

Contact email
[email protected]
Phone number
+1 401 447 1809
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2014-01-01, Year

Headquarters

Postal code
02472
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
13
Total equity funding
$122.9M
Last funding
Series B / $75.5M / 2021-11-04
Last equity funding
Series B / $75.5M
Investors
19
Lead investors
8
Founders
3
Articles
8

Founders and investors

Founders

Jonathan ThonJoseph ItalianoSven Karlsson

Lead investors

Massachusetts Life Sciences CenterMedical Technology Enterprise ConsortiumNational Heart, Lung and Blood InstituteNational Institute of Allergy and Infectious DiseasesQiming Venture PartnersSymBiosis LLCU.S. Department of DefenseZiff Capital Partners

Investors

K2 HealthVenturesMassChallengeQiming Venture PartnersU.S. Department of DefenseVivo Capital